Lv4
478 积分 2023-04-12 加入
Circulating Transcriptome Analysis Finds Gene Signatures and Immune Cell Activation and Abundance Predict Response to Immunotherapy in Bladder Cancer
6天前
已完结
Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial
1个月前
已完结
Cerebrospinal fluid circulating tumor DNA profiling for risk stratification and matched treatment of central nervous system metastases
2个月前
已完结
Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data
3个月前
已完结
Molecular subtyping of small-cell lung cancer in clinical practice: Primary tumor–lymph node concordance, intratumoral heterogeneity, and genomic context in a Chinese cohort
3个月前
已完结
Phase II Multi-institutional Clinical Trial Result of Concurrent Cetuximab and Nivolumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
3个月前
已完结
Emerging EGFR-Targeted Therapy in Head and Neck Cancer
3个月前
已完结
Finotonlimab with chemotherapy in recurrent or metastatic head and neck cancer: a randomized phase 3 trial
3个月前
已完结
Emerging advances in defining the molecular and therapeutic landscape of small-cell lung cancer
4个月前
已完结
Multi-omic characterization of nasopharyngeal carcinoma delineates the subtype-specific landscape of response to induction chemotherapy
5个月前
已完结
皖公网安备34019202002308
